Provided by Tiger Trade Technology Pte. Ltd.

Genelux Corporation

2.72
-0.0200-0.73%
Volume:223.75K
Turnover:609.61K
Market Cap:123.07M
PE:-3.15
High:2.81
Open:2.78
Low:2.68
Close:2.74
52wk High:8.54
52wk Low:2.29
Shares:45.25M
Float Shares:36.90M
Volume Ratio:0.61
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8623
EPS(LYR):-0.8647
ROE:-177.93%
ROA:-77.89%
PB:7.64
PE(LYR):-3.15

Loading ...

Genelux Publishes Corporate Presentation Highlighting Olvi-Vec Late-Stage Ovarian Cancer Program Focused on Platinum Sensitization

Reuters
·
Aug 14

Genelux Q2 EPS $(0.21) Misses $(0.19) Estimate

Benzinga Earnings
·
Aug 14

Genelux Posts Wider-than-Expected Q2 Loss on Higher R&D Expenses

Reuters
·
Aug 14

Press Release: Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates

Dow Jones
·
Aug 14

Genelux Q2 FY26 Net Loss Widens to $9.47 Million; Revenue Flat at no Revenue

Reuters
·
Aug 14

Genelux Corp Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Reuters
·
Aug 01

Attovia Therapeutics Appoints John W. Smither to Board of Directors

THOMSON REUTERS
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 30

Genelux Reports Viro-15 Translational Analysis Supports Olvi-vec Immune Activation, Platinum Resensitization in Ovarian Cancer

Reuters
·
Jun 30

Genelux shareholders elect John Smither to board at annual meeting

Reuters
·
Jun 23

Genelux director Thomas John disposes of 10,000 common shares worth $29,801

Reuters
·
Jun 03

Genelux Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Genelux Q1 net loss widens, misses analyst expectations

Reuters
·
May 08

Genelux Q1 EPS $(0.20), Inline

Benzinga Earnings
·
May 08

Genelux Q1 2026 net loss widens to $8.9 million; no revenue

Reuters
·
May 08

Press Release: Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates

Dow Jones
·
May 08

Genelux Corp expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 02

Genelux announces annual shareholder meeting webcast

Reuters
·
Apr 29

Genelux announces Olvi-Vec partnership payment of USD 11 million from Newsoara Biopharma

Reuters
·
Mar 23

Genelux Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Mar 20